Peptides for Joint and Tendon Injuries: The Orthopedic Evidence

If you've had a tendon that won't settle or a knee that aches on every stair, you've probably seen the claim: peptides like BPC-157 and TB-500 "heal" tendons, ligaments and joints. Orthopedic surgeons are asked about this constantly now. So what does the orthopedic literature actually contain? When a group of sports medicine researchers went looking in 2025, they found 35 animal studies and one human study.

This article looks at what the animal studies suggest, what the human data really consists of, how that compares with the options orthopedic clinicians already use, and how to decide whether a peptide conversation makes sense for your injury.

Why tendons are hard to heal

Tendons and ligaments have a relatively poor blood supply compared with muscle, and their cells turn over slowly. That's why tendon problems often drag on for months, and why people become open to anything that promises to speed things up.

It's also why "healing" is a slippery word in this area. A tendon can feel less painful without being structurally stronger, and it can look better on a scan while still hurting. Good studies measure specific things, such as pain scores, function, strength, and sometimes imaging, and compare them with a control group, because many tendon and joint complaints improve with time and rehabilitation alone.

What the animal research on BPC-157 shows

BPC-157 is a 15-amino-acid synthetic peptide derived from a protein found in gastric juice. Most of its research comes from a single research group in Croatia, largely in rats.

The 2025 systematic review by Vasireddi and colleagues, published in HSS Journal (the musculoskeletal journal of Hospital for Special Surgery), gathered studies from 1993 to 2024. In animal models, BPC-157 was reported to improve healing outcomes in muscle, tendon, ligament and bone, and the preclinical work suggested effects on blood vessel growth, growth hormone receptor expression and inflammatory signaling.

Those are reasonable grounds for human research. They are not evidence that the same thing happens in a person's Achilles tendon or rotator cuff. Rodent tendons differ from human ones in size, loading and healing speed, and injury models in animals are created in a controlled way that real injuries aren't.

The one human orthopedic study, read closely

The clinical study in that review is Lee and Padgett, published in Alternative Therapies in Health and Medicine in 2021. It is worth knowing exactly what it was:

• Design: a retrospective review of patient charts from one practice, with no control or placebo group.
• Size: 16 patients with various types of knee pain completed follow-up. Twelve received BPC-157 injected into the knee; four received BPC-157 combined with thymosin beta-4.
• Outcome measurement: patients were contacted by phone six months to a year later and asked to rate their pain before and after, with no imaging and no standardized outcome instruments.
• Result: most patients reported that their knee pain improved.

The authors themselves called it a small study and acknowledged its limitations. Without a comparison group, it can't separate a peptide effect from natural recovery, other treatments, recall bias, or placebo response, which in knee pain studies is known to be substantial. It is a reason to run a trial, not a result to build a treatment plan on.

FDA reviewers who assessed BPC-157 ahead of the July 2026 advisory committee described the human studies available across all uses as short, small and insufficient to establish safety or effectiveness. For the full evidence and legal picture, see BPC-157 in 2026.

TB-500 and thymosin beta-4

Thymosin beta-4 is a naturally occurring protein involved in cell migration and tissue repair. TB-500 is a synthetic peptide marketed as a fragment or version of it. Laboratory and animal studies have explored thymosin beta-4 in wound, heart and eye repair. The leap to "TB-500 heals tendons in people" is not supported by controlled human trials that we are aware of. There's also a practical problem: products labeled TB-500 are not always the same molecule. Our explainer on TB-500 and thymosin beta-4 separates the two.

What about oral collagen and gelatin?

Collagen peptides are a different category: food-derived supplements, not prescription peptides. There is some interesting early human work. In a small randomized crossover study by Shaw and colleagues (American Journal of Clinical Nutrition, 2017), eight healthy men took vitamin C-enriched gelatin or placebo before brief bouts of rope-skipping. The higher dose doubled a blood marker of collagen synthesis, and serum from supplemented participants increased collagen content in lab-engineered ligaments.

That's a measure of collagen production in healthy volunteers, not proof of faster injury healing, but it's a lower-risk area to discuss with your clinician or physical therapist. More in what collagen supplements can and can't do.

How peptides compare with standard orthopedic care

The first rows aren't perfect. Orthopedics has its own debates about injections and PRP. But they have been tested in people, repeatedly, and clinicians know roughly what to expect from them.

The legal picture in 2026

At the July 2026 FDA Pharmacy Compounding Advisory Committee meeting, panelists voted 8–6 (with one abstention) to recommend BPC-157 and 8–6 to recommend TB-500 for the 503A bulks list. FDA's own reviewers had concluded none of the seven substances considered met the criteria. The votes are non-binding; FDA must go through notice-and-comment rulemaking to add a substance, and no final rule has been reported as of this writing. Legal analyses in August 2026 indicated these peptides still could not lawfully be compounded from bulk. Neither is FDA-approved. Rules change; verify with FDA. See the July 2026 peptide vote, explained.

Athletes: check before you treat an injury

Injured athletes are exactly the people most tempted to try a "healing peptide," and exactly the people with the most to lose. USADA has warned that BPC-157 is prohibited under the World Anti-Doping Agency's S0 category for non-approved substances, and thymosin beta-4 and related products fall under the Prohibited List's peptide category. Check with your anti-doping organization before using anything. See peptides and drug testing.

A sensible path for a stubborn tendon or joint

1. Get the diagnosis right. Tendinopathy, a partial tear, arthritis, bursitis and referred pain from the spine can feel similar. Imaging or an in-person exam may be needed.
2. Commit to a structured rehab program with a physical therapist, usually built around progressive loading, for long enough to judge it.
3. Address the drivers: training errors, body weight, sleep, footwear, blood sugar, and medications that affect tendons.
4. Discuss established options with a sports medicine or orthopedic clinician if progress stalls.
5. If you're considering a peptide, talk it through with a clinician who will explain the evidence, legal status and risks, rather than someone selling a "recovery protocol."

If you want that honest conversation, our peptide therapy consultations start with your injury history, your treatment so far, and what's lawfully available. We'll tell you if we think you need an in-person orthopedic assessment first, and we won't prescribe something just because you asked.

Common questions

Does BPC-157 heal tendons in humans?

That hasn't been shown in controlled human trials. Tendon healing effects have been reported in animal studies; the only human orthopedic study was a small, uncontrolled case series of knee pain.

Is TB-500 or BPC-157 better for joint pain?

There's no human evidence base strong enough to compare them. Neither is FDA-approved, and neither has been tested head-to-head in people.

Can I use peptides instead of physical therapy?

We wouldn't recommend it. Structured rehabilitation has far more human evidence for tendon and joint problems than any peptide, and skipping it can prolong recovery.

What should I bring to a consultation about a joint injury?

Imaging reports, notes from any physical therapy, a list of treatments you've tried, and a clear description of when and how the injury happened. Book a consultation when you're ready.